(S)-N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

ID: ALA4476642

PubChem CID: 155538637

Max Phase: Preclinical

Molecular Formula: C19H28N4O2

Molecular Weight: 344.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCn1cc(C(=O)N[C@H](C(N)=O)C(C)(C)C)c2cccnc21

Standard InChI:  InChI=1S/C19H28N4O2/c1-5-6-7-11-23-12-14(13-9-8-10-21-17(13)23)18(25)22-15(16(20)24)19(2,3)4/h8-10,12,15H,5-7,11H2,1-4H3,(H2,20,24)(H,22,25)/t15-/m1/s1

Standard InChI Key:  QDZHLYBDQFZWCJ-OAHLLOKOSA-N

Molfile:  

 
     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
    7.3712  -22.4934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6568  -22.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6517  -21.2639    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9476  -22.5024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0650  -23.4956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8673  -23.3205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1946  -22.1735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9384  -21.3972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1359  -21.2324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5900  -21.8501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7374  -24.2483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9211  -24.3390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5894  -25.0918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7731  -25.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4455  -25.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0771  -22.0817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7866  -22.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7903  -23.3043    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0735  -21.2645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7794  -20.8527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3640  -20.8590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4925  -22.0754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0687  -20.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8497  -22.6250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6506  -22.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  7  1  0
 25  5  1  0
  5  6  1  0
  6  4  2  0
 25  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  5 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  1 16  1  0
 16 17  1  0
 17 18  2  0
 16 19  1  1
 19 20  1  0
 19 21  1  0
 17 22  1  0
 19 23  1  0
 10 24  2  0
 24 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476642

    ---

Associated Targets(Human)

CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 344.46Molecular Weight (Monoisotopic): 344.2212AlogP: 2.86#Rotatable Bonds: 7
Polar Surface Area: 90.01Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.12CX LogP: 2.79CX LogD: 2.79
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -0.81

References

1. Moir M, Lane S, Lai F, Connor M, Hibbs DE, Kassiou M..  (2019)  Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids.,  180  [PMID:31319265] [10.1016/j.ejmech.2019.07.036]
2. Sparkes E, Cairns EA, Kevin RC, Lai F, Grafinger KE, Chen S, Deventer MH, Ellison R, Boyd R, Martin LJ, McGregor IS, Gerona RR, Hibbs DE, Auwärter V, Glass M, Stove C, Banister SD..  (2022)  Structure-activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA.,  13  (2.0): [PMID:35308023] [10.1039/d1md00242b]

Source